Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Recommendation to restrict the combined use of medicines affecting the Renin – Angiotensin (RAS) system.(HPRA article in Irish Medicines Formulary - August 2014)
Notice type:
3rd Party Publications
Date:
01/08/2014
Further Information:
Please find the Article submitted in the latest version of the Iirsh Medicines Formeulary linked below
Recommendation to Restriict the combined use of medicines affecting the Renin-angiotensin (Ras) system (IMF - HPRA Article)
« Back
Date Printed: 01/05/2024